Key result
The 5-HT2B receptor antagonist SB 204741 partially reversed cardiac hypertrophy and attenuated myocardial apoptosis in rats with noradrenaline-induced cardiomyopathy (P<0.05).
Why the study?
Does 5-HT2B receptor antagonism reduce cardiomyocyte apoptosis and hypertrophy in noradrenaline-induced cardiomyopathy in rats?
Does 5-HT2B receptor antagonism reduce cardiomyocyte apoptosis and hypertrophy in noradrenaline-induced cardiomyopathy in rats?
p-value: p=<0.05
5-HT2B receptor antagonism attenuates cardiomyocyte apoptosis and hypertrophy in a rat model of noradrenaline-induced cardiomyopathy.
Provides preclinical support for 5-HT2B antagonism in cardiomyopathy; leaves open translation to human disease.
Serotonin (5-hydroxytryptamine; 5-HT) plays important roles in the development of cardiac hypertrophy via activation of 5-HT receptors. The aim of the present study was to investigate the role of 5-HT(2B) receptors in the development of cardiomyocyte apoptosis and hypertrophy associated with noradrenaline (NA) overload. 2. Cardiac hypertrophy was induced in rats by intraperitoneal injection of 1.5 mg/kg NA for 4 weeks. Starting from Day 15, 5-HT2B receptor antagonist SB 204741 (i.p., 0.5 or 2 mg/kg) or SDZ SER 082 (i.p., 1 mg/kg) was injected twice daily for another 14 days. Whole-cell patch-clamp techniques were used to record ionic currents in freshly isolated ventricular cardiomyocytes. Western blot and terminal deoxyribonucleotidyl transferase-mediated dUTP-digoxigenin nick end-labelling (TUNEL) assays were used to assess myocardial apoptosis. 3. Expression of 5-HT(2B) receptors was enhanced in the hypertrophic left ventricle induced by NE overload in vivo. The 5-HT(2B) receptor antagonist SB 204741 partially reversed cardiac hypertrophy induced by NE overload (P < 0.05) and decreased L-type calcium currents in ventricular cardiomyocytes (P < 0.05). In addition, SB 204741 notably attenuated myocardial apoptosis, as evidenced by downregulation of Bax and caspase 3 (P < 0.05) and upregulation of the anti-apoptotic Bcl-2 protein (P < 0.05). 4. In conclusion, the data suggest an involvement of 5-HT(2B) receptors in the generation of apoptotic events associated with cardiac remodelling during increased adrenergic stimulation.
No takes yet. Share an insight, caveat, or question.
Bai et al. (2010) studied Noradrenaline-induced cardiomyopathy. 5-HT2B receptor antagonist SB 204741 or SDZ SER 082 was evaluated on Cardiac hypertrophy and myocardial apoptosis (p=<0.05). The 5-HT2B receptor antagonist SB 204741 partially reversed cardiac hypertrophy and attenuated myocardial apoptosis in rats with noradrenaline-induced cardiomyopathy (P<0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: